Randomised control clical trial to the efficacy of bhunimba vati in the management of garbhini chardi w.s.r to emesis gravidarum

Bhunimba vati verses doxylamine succinate - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080506

Enrollment

Registered

2025-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O268- Other specified pregnancy relatedconditions

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed as garbhini chardi in first trimester of pregnancy

Exclusion criteria

Exclusion criteria: 1. Pregnancy with Convulsive disorder and fetal Anomalies. 2.Pregnant women suffering from Communicable disease ,gestational diabetes,Hypertension ,Cardio vascular Disease ,Asthama,Severe gastrointestinal infections ,Tuberculosis and Serological Disorder. 3.Pregnant suffering from multiple pregnancy ,ectopic pregnancy. 4.Gynecological conditions like fibroids, torsion of ovarian cyst and septic abortion with peritonitis. 5. Uncooperative pregnant patients. 6. pregnant with severe anemia (less than 8gm%).

Design outcomes

Primary

Measure	Time frame
Relief from symptoms of emesis gravidarumTimepoint: Seven days	—

Secondary

Measure	Time frame
No emesis gravidarumTimepoint: In 7 days	—

Countries

India

Contacts

Public ContactDr Sunil more

chaitalisnikam@gmail.com9511674664

Outcome results